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Introduction 
 Chronic pancreatitis is a benign inflammatory disease characterised by 
progressive & permanent destruction of pancreas parenchyma resulting in 
endocrine and exocrine insufficiency. Alcoholism is the common etiology in 
western population, other etiological factors include hereditary, autoimmune, 
tropical pancreatitis, malnutrition and idiopathic. Tropical pancreatitis is the 
commonest etiology in Indian population. Patients with chronic pancreatitis 
present with episodic, chronic abdominal pain. They can present with functional 
insufficiency such as steatorrhoea, weight loss or malnutrition and the 
development of diabetes mellitus. Most patients of chronic pancreatitis are 
managed medically, however up to 20% patients may require surgery. The main 
indication for surgery in the management of chronic pancreatitis is intractable 
pain.  Other indications include biliary & pancreatic ductal obstruction , mass 
effect  impinging on other organs or suspicion of malignancy. A number of 
surgical procedures have been developed in the 20th century. Literature review 
indicates maximum efficacy of any procedure is up to 85 to 90%. The surgical 
treatment is based on two main concepts – drainage procedure & resective 
procedure. Some procedures have combined both the concepts. Surgery for 
chronic pancreatitis is technically demanding. Localising the calculi, 
identification of duct, cystic lesion, assessment of associated mass lesion , 
relationship to vascular structures are sometimes difficult to assess because of 
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dense fibrosis. In recent years, the preoperative assessment of chronic 
pancreatitis has been significantly improved by use of imaging techniques.  
Imaging modalities such as ultra sonogram (USG), computerised tomography 
(CT), magnetic resonance imaging (MRI), endoscopic retrograde cholangio 
pancreaticogram (ERCP) & endosonogram (EUS) have greatly facilitated 
surgical care . Although such preoperative evaluation is key to surgical 
management, imaging can be used in the operating room to enable to enable the 
surgeon to attain further information about the clinical problem. To complement 
direct exploration, operating imaging has been applied to many fields of 
surgery. For the pancreas, a procedure that appears to be highly applicable for 
operating imaging is real time ultra sonogram.  Intra operative ultra sonogram 
(IOUS) is a newer application used in surgery of chronic pancreatitis to define 
lesions, characterise them & delineate their anatomic relationship and 
influencing the surgical procedure. 
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Review of literature 
Intra operative ultra sonogram (IOUS) 
 Intra operative ultra sonogram (IOUS) was first used by Dr. Bernard 
Sigel a general surgeon for intra operative diagnosis of biliary calculi. In the 
early 1980’s IOUS was employed during neurosurgery, endocrine surgery & 
cardio vascular surgery. Later IOUS expanded to hepatobiliary, pancreatic & 
other abdominal surgery. IOUS of the pancreas was described in 1980 by 1980 
by Lane & Glazer. Although there have been many advances in cross sectional 
imaging technologies, unparalleled special & contrast resolution of IOUS still 
makes it useful adjunct to pancreatic surgeons. It can be used to define lesions, 
characterise them, and delineate the anatomical    relationship, and to evaluate 
pancreatic & biliary ductal system. IOUS was useful for surgery in chronic 
pancreatitis in 69% of patients. [1] 
 
Choice of transducer:  
 IOUS of pancreas is performed best with an end fire transducer. [2] 
Typical frequencies used are 7.5 to 10 MHz, colour Doppler imaging is 
mandatory & pulsed wave Doppler can be extremely useful. 
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Indications for IOUS 
1 Acquisition of new information not otherwise available 
2 As a compliment to or replacement of intra operative radiography 
3 Confirmation of completion of operation  
4 Guidance of surgical procedure   
 
Intra operative scanning: 
 Normal pancreas is usually slightly hyperecchoic. The gland is lobulated 
in upto 20% of patients. The ecchogenicity of pancreatic tumours vary relative 
to the pancreas. Calculi are hyperecchoic with acoustic shadowing. The 
pancreatic duct is hypereccoic, when it is less than 1mm it appears as a 
ecchogenic line. Cystic lesions appear as hypoecchoic. Vascular anatomy of 
adjacent major vessels is clearly made out in IOUS using Doppler. Some 
difficulties encountered in IOUS include, fatty infiltration or lobulation can be 
misinterpreted as true lesion. Pseudocyst & pseudoaneursm can be confused if 
Doppler evaluation is not used. 
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IOUS in surgery for chronic pancreatitis:  
 IOUS can be used in many ways to assist surgeon as part of this 
procedure. The course of pancreatic duct, which is variable at the best of times 
and unpredictable in CP, is assessed by radiologist & a suitable point, where the 
duct is superficial is marked. If there are intraductal calculi, they can be 
removed or a point proximal to obstructing calculus can be used for drainage. 
The surgeon cuts down at this point to the duct, alternatively and preferably the 
duct can be cannulated with a needle under direct sonographic visualisation & 
can be cannulated with a wire. IOUS localisation of PD saves considerable 
operating room time because of rock hard fibrotic pancreas prevents accurate 
localisation by palpation. IOUS have a valuable role in identifying small 
pseudocyst and guiding the management. Chronic pancreatitis is associated with 
increased risk of pancreatic pancreatic cancer, IOUS guides in intraoperative 
FNA/biopsy from areas with abnormal ecchotexture there by altering the 
surgical procedure if the lesion is positive for malignancy. 
 
Advantages & disadvantages of IOUS 
 IOUS has number of advantages including safety, speed, high accuracy, 
more imaging information & ability to guide procedure. It can be used 
repeatedly & results obtained immediately. IOUS can be completed in short 
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time. Size, shape of target lesions are imaged with IOUS precisely& relation to 
adjacent vascular structures are clearly assessed. Disadvantages include need for 
special instrument & prolonged learning curve. Lesions smaller than 3-5 mm 
are not detectable even with high resolution USG , when tumours  are 
isoecchoic to surrounding parenchyma lesions will be difficult to detect. Finally 
IOUS is highly operator dependent.     
 
Surgery for chronic pancreatitis: 
 Intractable pain of pancreatic origin represents the most important 
indication for surgical intervention. Surgery is also indicated to control 
complications related to adjacent organs, such as distal CBD stenosis & 
segmental duodenal obstruction, not permanently controlled pancreatic 
pseudocyst in conjunction with ductal pathology & conservatively not amenable 
internal pancreatic fistula. Occasionally the inability to exclude pancreatic 
cancer despite broad diagnostic work up also necessitates surgery. Goals of 
surgical treatment for chronic pancreatitis are as follows: 
• Pain relief 
• Control of pancreatitis – associated complications of adjacent organs. 
• Preservation of endocrine & exocrine function. 
7 
 
• Social and occupational rehabilitation. 
• Improvement of quality of life. 
 The ideal surgical procedure should be based not only on associated 
problems but also on the pathogenesis of pain in patients with chronic 
pancreatitis. Surgeries for chronic pancreatitis can be broadly classified as 
1 Drainage procedure:  Longitudinal Pancreatico Jejunostomy -Partington-
Rochelle modification of Puestow procedure. (LPJ) 
2 Resectional procedure: Pancreaticoduodenectomy- Whipple’s (classic & 
pylorus preserving), Distal pancreatectomy, Total pancreatectomy with 
islet auto transplantation, Child’s procedure, Beger’s  procedure. 
3 Resection with extended drainage procedure: Frey’s procedure, Long 
itudinal V-shaped excision of ventral pancreas (Izbicki). 
Pathogenesis of pain in chronic pancreatitis:- 
Ductal and parenchymal hypertension:  
The assumption that pain in patients with chronic pancreatitis is caused 
by ductal hypertension is based on three observations. First, many patients 
exhibit a ductal dilatation that can be verified by ultrasonography, computed 
tomography, or endoscopic retrograde pancreaticography. Second, increased 
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pressure in the pancreatic ductal system is observed [3]. Finally, 
decompression of the pancreatic duct leads to at least temporary pain relief 
[4,5]. Increased intraductal and intraparenchymatous pressure in patients with 
chronic pancreatitis were observed independently by several authors[3,6,7]. 
Interestingly, patients with the "small duct entity" of chronic pancreatitis also 
exhibited ductal and parenchymatous  hypertension[8].  In addition, a strong 
correlation between intrapancreatic pressure and intensity of pain was 
shown[9,10]. Experimental studies relating to the pathogenesis of chronic 
pancreatitis led to the definition of a retroperitoneal compartment syndrome, 
indicating an intraparenchymatous hypertension[11,12], which resulted in 
reduced pancreatic blood flow and reduction of the intrapancreatic pH level, 
especially after stimulation of the exocrine pancreatic secretion, which 
normalized again after decompression of the pancreas [11,12]. These 
observations eventually led to the concept of decompression of the main 
pancreatic duct system by surgery 
 
Perineural Alterations: 
Other hypotheses on the pathogenesis of pain in patients with chronic 
pancreatitis are rather inadequately addressed by drainage operations alone. 
Chronic pancreatitis is regarded as chronic inflammation, characterized by 
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recurrent bouts of acute exacerbations, which eventually result in a defective 
restitution after acute pancreatitis [13,14]. This may lead to the generation of 
an inflammatory tumour, with a concomitant increase of the extracellular 
matrix and a loss of pancreatic parenchyma. At the same time, perineural 
inflammatory infiltrates arise, with a consecutive loss of the barrier 
functioning of the perineurium and concomitant neural sprouting [15]. Based 
on these findings, some centres favour resection as the therapeutic main 
principle in the treatment of patients with chronic pancreatitis [16,17]. 
 
Pancreatic duct drainage 
 
 Rational for drainage procedure s based on the assumption that pain in 
patients with chronic pancreatitis is caused by ductal hypertension. After the 
report by Duval in 1954, who described caudal pancreatojejunostomy with 
pancreatic tail resection, the technique for surgical decompression of the 
pancreatic ductal system in patients with CP was modified by Puestow and 
Gillesby in 1958. They described "retrograde" pancreatic ductal drainage 
involving a longitudinal anastomosis between the main pancreatic duct and a 
Roux-en-Y jejuna loop. Their original procedure also involved distal pancreatic 
tail resection and splenectomy to allow for long-segment pancreatojejunostomy. 
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In 1960, Partington and Rochelle [18] proposed a modification which primarily 
advocated the direct anastomosis of the anterior surface of the pancreas to the 
jejunum. This simplification not only allows preservation of the spleen but also 
reduces the amount of pancreatic mobilization that is required, thereby 
decreasing operation time and blood loss. They also described that the ductal 
decompression should encompass the whole length of the ductal from the tail of 
the pancreas to the pancreatic head; the advantage of this extended 
decompression is that the removal of pancreatic duct calculi is greatly 
facilitated. This modified Puestow procedure, longitudinal 
pancreaticojejunostomy (LPJ), addresses the multiple obstructions typically 
seen in these patients and remains the preferred ductal decompression procedure 
for CP [19]. LPJ should be considered for patients with CP and a dilated (≥ 7 
mm) main pancreatic duct of Wirsung [20]. Operative technique includes wide 
exposure of the anterior aspect of the pancreas from head to tail by opening the 
gastrocolic ligament, hepatic flexure mobilization, and a Kocher manoeuvre 
[20,21,22]. The dilated pancreatic duct can often be identified by palpation, and 
the location of the pancreatic duct is confirmed by a needle to aspirate ductal 
fluid. Intraoperative ultrasound may be useful when the duct is not readily 
palpable. The duct is incised longitudinally as extensively as required and all 
pancreatic ductal calculi are extracted. A Roux en - Y jejunal limb is 
constructed about 30 cm distal to the ligament of Treitz and a side-to-side 
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Roux-en-Y retrocolic pancreatojejunostomy is then created. A review of 
numerous series with this procedure reports that LPJ relieves chronic abdominal 
pain in 65%-93% of patients[20,21]. Morbidity and mortality rates are generally 
low, averaging 20% and 2%, respectively. The largest series has been reported 
by Nealon and Matin[23] who reviewed the surgical treatment of 124 patients 
with CP who had undergone a modified LPJ. At a mean follow-up of 6.5 years, 
106 of 124 patients experienced complete resolution of pain as defined by 
absence of narcotic use. Successful operation seems to be related to both 
technique and patient selection. Bradley has reported that ductal decompression 
of less than 6 cm is associated with inadequate relief of pain compared with 
greater than 6 cm of decompression. Furthermore, duct size greater than 7 mm 
also correlated with success.Finally, Tantia et al[24] and Kurian and Gagner[25] 
have reported the technical feasibility of laparoscopic LPJ. Despite these 
encouraging results, long-term follow-up of patients after LPJ reveals that up to 
50% of patients develop recurrent symptoms and 10%-35%fail to obtain pain 
relief [26, 27].  
 
Pancreatic resection: 
Longmire's hypothesis that the pancreatic head is the "pacemaker" for 
pancreatic pain in CP[28], that neural inflammation is an important pathologic 
mechanism of pain, the intractable pain from head-dominant small-duct 
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disease[29], the high incidence of ductal alteration, and an inflammatory mass 
in the head of the pancreas[30,31] are the most common indications for 
pancreatic resection as the treatment of choice for patients with chronic 
pancreatitis. 
 
Pancreatoduodenectomy (Whipple's procedure): 
 
This procedure was originally described for resection of periampullary 
malignancies, but it also also been used in the surgical management of patients 
with CP. It is a safe procedure with a hospital mortality of 0%-5%, and a 
postoperative pain relief of 50%-75% at a long-term follow-up period.[32] 
associated with poor long-term results in patients with CP: poor postoperative 
digestive function including dumping, diarrhoea, peptic ulcer, dyspeptic 
complaints, and diabetes mellitus which is responsible for the late postoperative 
morbidity and mortality in these patients. The long-term surgical results, 
especially regarding quality of life of patients, are disappointing in some studies 
[33]. 
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Pylorus-preserving pancreatoduodenectomy (PPPD): 
 
This technique was described by Traverso and Longmire in 1978. They 
tried to minimize the derangements in gastrointestinal physiology observed in 
patients who had undergone a Whipple resection, including weight loss, 
diarrhoea, dumping, delayed gastric emptying, and marginal ulceration. A long-
term follow-up has shown that there is a significantly reduced incidence of 
gastrointestinal disturbances after PPPD when compared with the Whipple's 
procedure[ 34], and a better quality of life after the PPPD[35]. One large 
retrospective study found comparable results in postoperative pancreatic 
function comparing these procedures, while Berberat et al reported that the 
maintenance of a near normal upper gastrointestinal tract was shown to reduce 
the incidence of post operative steatorrhoea and exocrine insufficiency when 
compared with the Whipple's procedure. However, Müller et al reported three 
major drawbacks of PPPD in patients with CP: the increased incidence of 
postoperative sequalae of transient delayed gastric emptying (30% to 50%), 
which often is associated with slower weight gain; the risk of cholangitis; and 
the long-term occurrence of exocrine and endocrine pancreatic insufficiency in 
more than 45% of patients. 
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Distal pancreatectomy (DP): 
 
DP is a safe procedure, with a perioperative mortality of 0%-3.8% and a 
morbidity of 15%-31%, that may be performed with or without splenectomy 
Sawyer and Frey emphasized that DP should be utilized only in appropriate 
patients with CP: pancreatic duct <5 mm diameter, disease seen on CT and 
ERCP to be restricted to the pancreatic body, tail, or both, and they also found 
adequate pain relief in 90% of patients with distal disease at a mean follow-up 
of 4 years. Rattner et al on the other hand, reported good pain relief in only 31% 
of patients undergoing DP for distal CP. In two recent studies, DP with splenic 
preservation controlled pain in 72%-82% of patients with CP.[36] Hutchins et al 
reported on a series of 90 patients who had undergone a DP for CP. Forty eight 
of 84 patients available for follow-up had zero or minimal abdominal pain. 46% 
of these patients became diabetic at a median follow-up of 2 years. Similarly, 
Schoenberg et al [37] reported 74 patients undergoing DP for CP with a median 
follow-up of 58 months; 88% of patients had significantly less pain and 66% 
had an increase in median body weight, while diabetes mellitus occurred in 22% 
of patients. 
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Total pancreatectomy (TP) : 
 
TP with duodenum and spleen preserving was carried out for benign 
disease that required removal of the whole gland. It was also indicated for 
patients with CP and disabling pain for whom the partial resection had 
failed[38], for those with total endocrine and exocrine pancreatic failure[39],  
and for those with hereditary pancreatitis or familial pancreatic cancer, as 
prophylaxis against cancer. The main contraindication for this procedure is the 
presence or suspicion of pancreatic malignancy. TP creates a significant 
postoperative morbidity in the form of insulin-dependent diabetes mellitus and 
exocrine insufficiency with malabsorption. However, the introduction of islet 
isolation and autotransplantation has led to renewed interest in TP as a treatment 
modality for end-stage CP. 
 
Duodenum-preserving pancreatic head resection (Beger's procedure): 
 
Duodenum-sparing resection of the pancreatic head was first described by 
Beger et al. Indications for this procedure include intractable abdominal pain, 
small duct CP, and head dominant disease. The Beger's procedure is 
contraindicated in circumstances in which pancreatic cancer is suspected. 
Surgical technique consists of ventral transection of the pancreatic neck and 
16 
 
subtotal head resection combined with Roux-en-Y loop of jejunum anastomosis 
to the distal pancreatic remnant and the rim of pancreatic tissue along the inner 
surface of the duodenum to restore gastrointestinal continuity. The goal of this 
technique is to treat only the enlarged pancreatic head, where the disease is 
mainly present, and to preserve the duodenum, which has a crucial role in the 
regulation of digestion and glucose metabolism. Beger et al[40] reported 26-
year experience with this procedure in 504 patients with CP and pancreatic head 
inflammatory mass. A median follow-up of 5.7 years demonstrated that 91.3% 
of patients were pain free following the Beger's procedure, and that the  hospital 
mortality was 0.8% and the late death rate was 8.9%-12.6%, compared to 
20.8%-35% for patients]without surgery as reported. No data concerning the 
effect of this procedure on steatorrhea or pancreatic enzyme requirements were 
provided. A randomized trial of 20 patients per procedure, Beger's procedure 
versus Whipple's procedure, showed that patients undergoing Beger's procedure 
had significantly less pain, increased postoperative weight gain, and better 
glucose tolerance at a 6-month follow up [19]. 
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Local  head resection with longitudinal pancreatojejunostomy (Frey's 
procedure): 
 
A modified Beger's procedure was described by Frey in 1987[31]. This 
procedure consists of a subtotal duodenum-sparing pancreatic head resection 
combined with LPJ. The resection in the head of the pancreas allows opening 
the main pancreatic duct as it courses posteriorly toward the duodenum and 
provides drainage of all pancreatic ducts by extending the Roux limb to the 
duodenum[41].  The operation is designed to avoid the more technically 
challenging aspects of the Beger's procedure, the division of the pancreatic 
neck, and the need for two separate pancreatic anastomosis. It is also described 
for patients who have "head-predominant" disease on the assumption that the 
pancreatic head, with fibrotic and obstructed ducts, is not adequately addressed 
by simply decompression of the main pancreatic duct with the Puestow 
procedure. It is also indicated for patients with small duct CP, and for patients 
with mild dilation and stricture of the proximal pancreatic duct[31]. The 
inability to exclude pancreatic malignancy is a contraindication to the 
performance of Frey's procedure. Operative results indicate that Frey's 
procedure has an operative mortality of 0% and a perioperative morbidity of 
22%[42]. Excellent pain relief was achieved in 74.5% of patients in a mean 
follow-up of 37 months, while progression of endocrine (11%) and exocrine 
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(11%) insufficiency was noted to be minimal and less than that for other 
procedures. Frey's procedure was also compared with PPPD in a prospective 
randomized trial at the University of Hamburg[33]. The morbidity rate was 
19.4% in the Frey group and 53.3% in the PPPD group; the pain score 
decreased after surgery by 94% and 95% respectively. A median follow-up of 2 
years, showed that the global quality of life improved by 71% and 43%, 
respectively.In a prospective randomized trial by Izbicki et al[43] the Frey's 
procedure was compared with the Beger's procedure. At a mean follow-up of 
1.5 years postoperatively, patients undergoing the Frey's or Beger's procedure 
demonstrated decreased pain scores of 94% and 95% respectively. Both patients 
groups had an increase of 67% in their overall quality of life indices, and there 
were no significant differences in postoperative endocrine and exocrine 
function. All types of pancreatic head resection are effective for the relief of 
pain from CP.  The procedure of choice is pancreatoduodenectomy (Whipple's 
procedure or PPPD) if there is mass lesion in head of pancreas with any 
possibility of malignancy in the background of CP. For patients with head 
predominant disease with a normal sized pancreatic duct that is devoid of 
stricture, Beger's procedure is preferable. For patients with chain-of-lakes-type 
anatomy, the Frey's procedure is the best choice because it addresses these 
abnormalities via the pancreatojejunostomy. Distal pancreatectomy is highly 
effective for patients with benign-appearing left-sided pancreatic duct stricture 
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with upstream duct dilation, or duct disruption not amenable to 
pancreatojejunostomy and for those with complications of pancreatitis limited 
to the distal pancreas such as pseudocysts or associated splenic vein thrombosis. 
 
Treatment of complications of CP: 
 
  Biliary stricture and duodenal obstruction which are well-known 
complications of CP occur in 6% and 1.2% of the patients, respectively[44].  
For patients requiring an operation for CP, the incidence increases to 35% for 
biliary stricture and 12% for duodenal obstruction[45].  Most patients will 
present with an elevated alkaline phosphatase and/or bilirubin level, but the 
initial presentation with clinical jaundice, cholangitis, or biliary cirrhosis is rare. 
Surgery is indicated if patients develop jaundice which seems to be due to 
progressive chronic disease and fibrosis or have an episode of cholangitis. The 
procedure of choice in pain-free patients with isolated biliary stricture is Roux-
en-Y choledochojejunostomy to bypass the obstructed intra-pancreatic portion 
of the common bile duct[46]. Choledochoduodenostomy and 
cholecystoenterostomy must be avoided whenever possible because they are 
associated with the high incidence of cholangitis[46].  Duodenal obstruction is 
usually found in patients with "head-predominant" version of chronic 
pancreatitis, in which the head is significantly enlarged (≥7 cm in diameter)[47]. 
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Isolated duodenal obstruction in patients with CP is much less common than 
obstruction of the common bile duct. For patients with isolated duodenal 
obstruction, the procedure of choice is gastrojejunostomy[48], while combined 
duodenal and distal bile duct obstruction is effectively controlled by duodenal-
preserving pancreatic head resection (DPPHR)[49], Pseudocyst complicates CP 
in 30% to 40% of patients[50]. Over the last several decades, several series have 
documented the feasibility of conservative treatment of asymptomatic 
pseudocysts. Based on these series, the current policy for patients with 
asymptomatic pseudocysts, regardless of size or duration, is nonoperative 
management. Treatment is reserved for patients with symptomatic pseudocysts, 
enlarging pseudocysts, or complications (infection, rupture, or pseudoaneurysm) 
related to the pseudocyst. Symptoms may include pain, early satiety, 
compression of the duodenum or stomach causing obstruction, and compression 
of the bile duct causing jaundice or abnormal liver function.  If the pseudocyst 
is adherent to the posterior wall of the stomach, the preferred operation is a 
cyst-gastrostomy. If the pseudocyst is in the head of the pancreas, adherent to 
either the first or third portions of the duodenum, and away from the ampulla 
and common bile duct, Roux-en-Y cystjejunostomy is advisable. For smaller 
intra-pancreatic pseudocysts within the pancreatic head, a Whipple's procedure 
may be appropriate. If the pseudocyst is small and located in the tail of the 
pancreas, DP is recommended. Rosso et al reported the success rates of 
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cystduodenostomy, cyst-gastrostomy, and cyst-jejunostomy were 100%, 90%, 
and 92%, respectively.  An increasing number of patients with CP are diagnosed 
with splenic vein thrombosis and secondary left-sided portal hypertension.[51] 
Heider et al[52] reported 55 patients with a diagnosis of CP and splenic vein 
thrombosis; 77% of patients developed gastrosplenic varices, while only 2 
patients had gastric variceal bleeding and required splenectomy. Splenectomy is 
the treatment of choice for symptomatic patients with left-sided portal 
hypertension caused by splenic vein thrombosis. Asymptomatic patients should 
be treated expectantly, as prophylactic splenectomy is indicated for those 
patients with splenic vein obstruction who are operated on for other 
complications of CP. Finally, the last group of indications for surgery in patients 
with CP relates to complications of ruptured pancreatic duct or leaking 
pseudocysts and includes internal pancreatic fistula, and pancreatic  ascites. 
Patients with a leaking pseudocyst or a disrupted pancreatic duct will be best 
treated, respectively, by a cyst or a pancreatic duct internal drainage, whereas 
DP should be indicated for those patients with a narrow disrupted duct. 
 
    Concomitant pancreatic cancer 
    There is an association between CP and an increased incidence of 
pancreatic cancer, especially in smokers.[53] The risk of pancreatic cancer in 
patients with CP varies from 2.3% to 26.7%,[54] whereas in patients with 
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hereditary pancreatitis it approaches almost 75% for patients with a paternal 
inheritance pattern.[55]. The association between chronic pancreatitis and 
cancer has been confirmed in a number of epidemiological studies. During the 
1980s, two small case-control studies noted an increased yet insignificant 
number of pancreatic cancers among patients with chronic pancreatitis [56,57]. 
Between 1990 and 1993, three studies noted a small but significant increased 
risk of pancreatic cancer in patients with chronic pancreatitis[58,59,60]. In 
1993, Lowenfels et al [61] published the results of the International Pancreatitis 
Study Group's multicenter historical cohort study of 2015 subjects with chronic 
pancreatitis. These subjects were recruited from clinical centers in six countries. 
A total of 56 cancers were identified among these patients during a mean 
follow-up of 7.4±6.2 years.  For subjects with a minimum of 5 years of follow-
up, the standardized incidence ratio was 14.4. The cumulative risk of pancreatic 
cancer in subjects with chronic pancreatitis for 10 and 20 years was 1.8% and 
4.0%, respectively. Furthermore, the risk of pancreatic cancer was independent 
of the underlying cause of chronic pancreatitis. Thus, the risk of pancreatic 
cancer in patients with chronic pancreatitis appeared to far exceed any other 
known risk factor, including cigarette smoking (relative risk from 8 studies 
varied from 1.2 to 3.1) [62]. 
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Evidence that tropical pancreatitis increases the risk of pancreatic cancer:  
 
The link between TP and pancreatic cancer is strong.  The incidence of 
pancreatic cancer among adult patients with TP is striking.  In 1992 Augustine 
and Ramesh [63] reported 22 pancreatic cancers among 266 patients with TP 
over an 8-year period (8.3%). In this cohort, the risk was highest after age 40, 
and patients with TP often had features of dysplasia as well as cancer in 
resected pancreatic specimens. In 1994 Chari et al [64] reported that over a 4.5-
year period 24 of 185 patients with TP died, and that 6 (25%) died of pancreatic 
cancer. The average age of onset was 45±7 years, and the relative risk compared 
with those without TP was 100. Other reports confirm these observations.65 
Thus, current evidence suggests that the risk of pancreatic cancer is very high in 
patients with long-standing TP 
  A high index of suspicion should be kept in mind, especially when there 
is an inflammatory mass in the pancreatic head associated with a dominant 
stricture of the pancreatic duct. Despite the adoption of sophisticated diagnostic 
tools (ERCP, CT, MRI, EUS, fine needle cytology) [66,67] in a high percentage 
of cases (up to 30%), it is impossible for the surgeon to say preoperatively 
whether a mass in the head of the pancreas is inflammatory or malignant.[68] 
This can be difficult even in the operating room using incisional biopsies,[69] 
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intra-operative ultrasonography[70], or pancreatic ductoscopy[71]. Therefore, 
when there is a strong suspicion of an underlying malignancy, a Whipple's 
procedure or a PPPD should be considered. 
 
Measurement of pain 
  Pain is a personal, subjective experience influenced by cultural learning, 
the meaning of the situation, attention, and other physiological variables. Until 
recently, the methods that were used for pain measurement include the use of 
verbal rating scales (VRS), numerical rating scales (NRS), and visual analogue 
scales (VAS). VAS is a simple and sensitive assessment that is often used to 
measure and study a patient’s pain .Its usefulness has been validated by several 
investigators. A VAS has been found to be superior to fixed interval scales, 
relative pain scales, and verbal reports of pain. Subjects simply place a mark on 
a 10cm line anchored with the terms describing the extremes of pain intensity.  
To quantify pain intensity more distinctly, a pain score comprising a visual 
analogue scale of pain, frequency of pain attacks, pain-related sick leave, and 
analgesic medication has recently been suggested and validated for use in 
patients suffering from chronic pancreatitis [72]. 
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Endocrine and Exocrine insufficiency: 
  Nealon et al[21]  reported that in patients with mild moderate chronic 
pancreatitis, operative decompression of pancreatic duct early in the course of 
the disease did not improve but halted the progressive loss of endocrine and 
exocrine functions.  According to these authors high intra – ductal pressure may 
contribute to the ongoing loss of function and perhaps to an ongoing level of 
subacute inflammation, which restricts utilization of nutritional substrates. 
 Hammel et al[61]  who, over a follow-up period of 15 year found that the 
prevalence of diabetes was 21% in 222 patients who had undergone surgery, in 
contrast to 33% in 224 patients managed conservatively 
In alcoholic chronic pancreatitis, the results of decompression surgery 
have been inconsistent with regard to improvement in endocrine and exocrine 
functions. Adams et al[4] in a retrospective study of 85 patients with alcoholic 
chronic pancreatitis, showed that insulin use continued in 23% and that taking 
of pancreatic enzyme supplements persisted in 34% after the modified 
Puestow’s procedure.  The author suggested that pancreatic exocrine and 
endocrine functions worsened after drainage surgery. 
In  Amman’s  study[88]  drainage surgery did not delay the development 
of exocrine or endocrine insufficiency in chronic alcoholic pancreatitis patients.  
The inconsistency of results in alcoholic chronic pancreatitis may reflect the 
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difference in the extent of pancreatic damage at the time of surgery and whether 
or not the patient has stopped drinking. 
 
Ramesh and Augustine[91]  reported that glucose tolerance improved in 
only 18% of their TP patients, while Sharma et al[89] noted that these was no 
significant change in insulin requirement after intervention. 
 
The two most striking changes in tropical calcification pancreatitis are 
marked atrophy of exocrine pancreas but more involving the islets of 
Langerhan’s  instead the latter  shown on consistent hypertrophy and 
hyperplasia. Further there is an unequivocal evidence of nesidioblastosis in 
tropical chronic pancreatitis. 
  
The most striking findings in alcoholic chronic pancreatitis, on the other 
hand are ductal dilatation with protein plugs, fat necrosis, parenchymal necrosis, 
acute inflammatory reaction, and parenchymal calcification[90]. The 
ductoinsular changes such as islet hypotrophy/ hyperplasia and nesidioblastosis, 
characteristically seen in tropical chronic pancreatitis, as mentioned earlier are 
rarely seen in alcoholic pancreatitis. This difference is pathology may explain 
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the variable changes in pancreatic dysfunction after drainage surgery in 
alcoholic chronic pancreatitis as opposed to that in tropical chronic pancreatitis. 
The possible explanation for the improvement in endocrine function after 
decompressive surgery in tropical chronic pancreatitis may lie in the fact that in 
this disease, the islet cells may be normal or even increased in number, in fact 
the K value (the slope of disappearance of glucose from the blood after 
intravenous injection) may be normal in patients with tropical chronic 
pancreatitis who have overt pancreatic diabetes.  It is postulated that obstruction 
of the pancreatic duct, together with the dense intralobular and perilobular 
fibrosis, creates a compartment syndrome and that the insulin deficiency results 
from poor islet perfusion syndrome and the poor insulin absorption due to raised 
interstitial pressures. 
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Aim of study 
 The aim of study was to analyze the usefulness of intra operative ultra 
sonogram (IOUS) in surgery for chronic pancreatitis and its benefits in the 
outcome of drainage surgery for chronic pancreatitis. 
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Materials & Methods 
Consecutive patients (n=52) with chronic pancreatitis who underwent 
drainage procedures (longitudinal pancreatico jejunostomy [LPJ] & Frey’s 
procedure) between Sep 2006 and Feb 2009 constituted the study population. 
The diagnosis of chronic pancreatitis was made on the basis of history of typical 
abdominal pain & pancreatic parenchymal changes, ductal dilatation & 
calcification on imaging {Ultra sonogram [USG], computerised tomography 
[CT] & or magnetic resonance cholangio pancreatography [MRCP]}. None of 
the patients with an enlarged head underwent an Endoscopic ultrasound (EUS) 
evaluation, as the facility was not available in our deptartment.  
Inclusion criteria were  
1. Intractable pain not controlled with analgesics associated with a 
dilated main pancreatic duct (MPD > 7 mm) [73]  
2. Inflammatory head mass with a dilated MPD 
3. Coexisting complications from adjacent organs (Biliary stricture, 
Duodenal stenosis, Pseudoaneurysm) 
Exclusion criteria were  
1. Patients with pseudocyst without duct involvement 
2. Intractable pain associated with small duct disease 
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3. Pancreatic fistula 
4. Portal vein thrombosis  
5. Chronic pancreatitis associated with malignancy  
Tropical pancreatitis was defined as chronic pancreatitis with younger age of 
onset, large intraductal calculi, with or without diabetes mellitus & steatorrhoea 
and without any evidence of other known etiolological factors. Alcoholic 
pancreatitis was defined as chronic pancreatitis associated with consumption of 
greater than 50 units of alcohol per week for at least 5 years. Consecutive 
patients were numbered, odd no’s underwent IOUS, even no’s did not undergo 
IOUS.  Group I (n=26): where IOUS was used during surgery and Group II 
(n=26): where IOUS was not used. Surgical factors analysed are duration of 
surgery, blood loss in surgery, post operative hospital stay, morbidity, mortality 
and usefulness of IOUS. Factors analysed in outcome are  
1. Pain relief after surgery. Pain was assessed using a visual analogue scale 
(VAS). Patients simply place a mark on a 10 cm line anchored with terms 
describing extremes of pain intensity. Pain relief was considered 
improved if VAS score was less than 5 compared to pre op VAS [49]. 
Pain relief was considered not present if difference between the pre 
operative & post operative VAS is less than 5 & if patient required 
hospital admission for pain relief after surgery. 
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Visual analog scale 
      
 
0 1 2 3 4 5 6 7 8 9 10 
No pain                   
Worst 
pain 
imaginable
 
2. Exocrine function was assessed by  presence of steatorrhoea, defined as 
frequency of more than three stools per day, foul smelling, greasy and 
pale stools[74]. 
3. Endocrine function – presence of diabetes mellitus defined as blood 
glucose level more than 200 mg/dl two hours after an oral glucose load of 
75 gm.  
4. Weight after surgery – considered significant when change was more than 
5 kg either loss /gain of preoperative weight[75].   
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Choice of surgery: 
All the surgeries in both the group of patients were performed by two 
experienced surgeons or under their supervision. Frey’s procedure was done 
when there was an associated head was enlarged & longitudinal pancreatico 
jejunostomy (Partington & Rochelle modification of Peustow procedure) was 
done in a normal sized head of pancreas. Head of pancreas was considered to be 
enlarged when its maximum diameter was more than 35 mm [76]. IOUS was 
done using an end fire transducer with 10 MHz probe with Doppler facility. 
Sterilisation was done as prescribed by manufacturer. IOUS was done by a 
scrubbed interventional radiologist attached to our department. IOUS was 
initially done after complete mobilisation & exposure of pancreas and later after 
ductal exploration before anastomosis. IOUS was considered beneficial during 
surgery for chronic pancreatitis when it was able to identify/locate/guide: 
1. Main pancreatic duct, which could not be identified 
2. Pseudoaneurysm,  
3. An undrained cystic lesion  
4. FNAC from mass lesions suspicious of malignancy 
5. Calculi which needed removal after surgical exploration   
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Data collection:  
Data was obtained during the hospital admission as well as during follow-
up at outpatient department by face to face interview or telephonic interview. 
Follow up period ranged from 2 to 29 months. 
Statistical analysis: 
 Data were reported as mean ± SD .Continuous variables such as duration 
of surgery, blood loss in surgery & pain score were analysed using student T 
test. Categorical variables such as weight, diabetic status, steatorrheoa were 
analysed using chi square test. The data were analysed using a statistical 
software package (SPSS 14 version for windows). A P-value of less than or 
equal to 0.05 was considered statistically significant.    
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Results 
 Fifty two patients were enrolled in the study. Preoperative details of 
patients are shown in Table 1. Both patient groups were comparable in terms of 
demography, etiology & pancreatic morphology. In the IOUS group, 21 patients 
had an enlarged head. On IOUS, 2 out of these 21 patients had a suspicious 
mass lesion in the head which was un-identified by previous imaging 
modalities. An IOUS guided FNA was done from the mass lesion and an 
immediate cytological diagnosis was obtained. One patient had an inflammatory 
pathology and one patient had a positive cytology for malignancy. Whipple’s 
procedure performed for the patient with cytology positive for malignancy. The 
patient was excluded from the study for further analysis.  
 
Tropical pancreatitis was the etiology for 18 (72%) patients in IOUS 
group and for 17(65%) patients in non- IOUS group. Alcoholic pancreatitis was 
the etiology in 7(38%) & 9(35%) patients respective groups. Mean age of TP 
patients in IOUS group was 28±12.64 & 30.47±10.39 in non IOUS group. Mean 
age of AP patients in IOUS group was 38.71±7.78 & 41.22±7.29 in non IOUS 
group. Mean duration of symptom was 4.08 yrs in IOUS group & 4.38 in non 
IOUS group. 9 (36%) patients were diabetic in IOUS group & 11 (42%) patients 
in non IOUS group. Steatorrhoea was present in 6 (24%) patients in IOUS 
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group & 7(27%)in non IOUS group. Frey procedure was performed in 20(80%) 
IOUS group & 19(73%) in non IOUS group; 5(20%) patients underwent LPJ in 
IOUS group & 7(27%) in non IOUS group. Mean diameter of MPD in IOUS 
group was 9.56±2.50 & 9.30±2.95 in non IOUS group (Table 1). 
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Table 1 Demography of IOUS & non IOUS group patients 
 IOUS Non IOUS 
Total no patients 25 26 
Male  17 18 
Female  8 8 
Tropical pancreatitis  18 17 
Alcoholic pancreatitis 7 9 
Age mean ± SD of TP 28 ± 12.64 30.47 ± 10.39 
Age mean ± SD of AP 39 ± 7.78 41 ± 7.29 
Diabetes Mellitus (%) 9(36%) 11(42%) 
Steatorrhoea(%) 6(24%) 7(26%) 
Pain duration  yrs mean  4.08 4.38 
Diameter MPD mean ± SD  9.56 ± 2.50 9.30 ± 2.95 
Frey’s procedure  20 19 
LPJ 5 7 
Post op stay mean ± SD  11.44 ± 3.5 12.92 ± 5.5 
Follow up mean ± SD 15.04 ± 6.2 16.03 ± 6.48 
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Figure 2: Etiology of CP -  IOUS & non IOUS group 
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Figure 3: Surgery detail in IOUS & non IOUS 
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IOUS was beneficial per-operatively in 19 (73%) of patients. As all the 
patients had a dilated MPD, it could be easily identified per-operatively without 
the added use of IOUS. However, it had added benefits (Table 2 & Figure 4).  
IOUS altered the management plan in one patient. IOUS identified mass 
lesion in 2 patients which was not identified by preoperative imaging. It was 
useful to locate calculi in 16 patients, identified an undrained cyst in 3 patients, 
localised pseudoaneursym in 1 patient , in some patients it was useful for two 
different purposes. Mean duration of surgery in IOUS group 217.6 ± 28.10min 
and in non IOUS group 202 ± 23.92 min.  Blood loss in IOUS & non IOUS 
group were 251 ± 79.27 ml and 285 ± 100.3 ml respectively. Mean follow up in 
IOUS group was 15.04±6.2 months, in non IOUS group it was 16.03±6.48 
months. There was no hospital mortality in both the groups. Morbidity was 
observed in 5(20%) patients in IOUS group & 6(23%) patients in non IOUS 
group. Both group had minor pancreatic leak in one patient both were managed 
conservatively.  
 There was no hospital mortality in both the group of patients.  Morbidity 
was 5(20%) in IOUS group & 6(23%) in non IOUS group. One patient in each 
group had minor pancreatic leak which were managed conservatively. Other 
complications were surgical site infection, pulmonary complication managed 
appropriately. Post op stay in IOUS group 11.44 ± 3.5 days and in non IOUS 
group 12.92 ± 5.5 days. One patient developed post op bleed from 
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gastroduodenal artery, relaprotomy & suture ligation of the bleeding vessel was 
done in non IOUS group.   
   Of 9 patients with diabetes in IUOS group the status remained 
unchanged in 8; one patient became non diabetic after surgery, this was a TP 
patient who had DM 6 for month duration. One patient developed DM a year 
after surgery. In non IOUS group of 11 patients  
Table 2: Benefits of IOUS in the IOUS group (26 patients) 
Benefits of IOUS in the IOUS gr. (26 patients) No of patients 
Identify stones prior to anastomosis 13 
Detected undrained cystic lesion 1 
Detected both stones and undrained cystic lesion 2 
Localised  pseudoaneurysm 1 
Detected mass lesion & guided FNA 2 
Benign  1 
Malignancy  1 
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Figure 4: IOUS use in IOUS group 
 
N=26 
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Figure 5 : IOUS picture showing ductal calculi 
 
Figure 6 : IOUS picture showing parenchymal calculi 
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Figure 7 : IOUS picture showing dilated MPD 
 
Figure 8 : IOUS picture showing undrained cyst 
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had  DM, of them 9 patients remained diabetic, 2 patients became non diabetic, 
both were TP patients who underwent Frey procedure with duration of DM less 
than one year. One patient developed DM 18 months after surgery, this TP 
patient underwent LPJ.    
In IOUS group 3 patients developed steatorrhoea after Frey procedure, 
two cases of TP, & one case of AP.  In non IOUS group 5 patients developed 
steatorrhoea after surgery, all patients of TP, 3 had Frey procedure, 2 patients 
underwent LPJ. 
 Weight remained unchanged in 15 patients of IOUS group, 7 gained 
weight & 3 patients developed decrease in weight after surgery. In non IOUS 
group, weight remained unchanged in 11, weight gain in11 patients and weight 
loss in 4 patients.   
  Pain relief was seen in 21(84%) and 21(81%) patients in IOUS and non 
IOUS group respectively. 2 patients in IOUS & non IOUS group underwent 
celiac plexus block with relief of pain. Other three patients in each group 
continued take analgesics. 
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Table 3 Post OP variable analysis 
Parameters  IOUS Non IOUS P- value 
Duration of surgery (min) M±SD 202.11±28.92 217±28.10 Ns 
Blood loss in surgery (ml) M± SD 251±79.27 285±100.3 Ns 
No. of patients with  pain relief  21(84%) 21(81%) Ns 
Diabetic status  
Non DM - No change 
New onset  
Prev. DM - No change 
Prev. DM – non DM 
 
 
15 
1 
8 
1 
 
14 
1 
9 
2 
Ns 
Stetorrhoea 
No steat. – no change 
New onset steat. 
Prev. Steat. – no change 
Prev. steat. – non steat. 
 
 
16 
3 
6 
0 
 
14 
5 
6 
1 
Ns 
Weight 
Improved  
Same 
Decreased  
 
 
7 
15 
3 
 
11 
11 
4 
Ns 
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Discussion 
Our mortality and morbidity rate associated with the procedures is well 
within the acceptable range. Major postoperative complications in the current 
series include pancreatic leakage and delayed arterial bleeding. Arterial 
bleeding is a major life threatening complication following head coring in the 
range of 2% to 3% [76]. Bleeding follows erosion of peripancreatic vessels by 
pancreatic fluid from an insufficient anastomosis or due to rupture of 
pseudoaneurysm [77]. One patient required relaparotomy and ligation of 
pancreaticoduodenal artery. Since the patient presented with severe intra 
abdominal bleeding, angiography and embolization was not considered in this 
patient. 
            IOUS beneficial for the surgery in 73% of our patients. It detected 
malignancy undetected by preoperative imaging in one patient, there by altering 
the management. The calculi detected in IOUS were mainly in head, uncinate 
process near the major vessels & from secondary ducts. With IOUS guidance 
the calculi were removed with minimal tissue destruction.  Un drained cystic 
lesions: two in the uncinate process & one in the tail, were drained. The 
duration of surgery was not statistically different between the two groups. Blood 
loss during the surgery, though found to be less in the IOUS group, was not 
statistically significant. 
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The outcome of surgery in relation to pain relief, endocrine, exocrine 
insufficiency & weight, were not statistically significant between the two 
groups. We have not included small duct diseases where IOUS is very helpful in 
identifying MPD. Bernard Sigel et al had shown that IOUS was useful in 69% 
of operations for the complications of pancreatitis [78]. Kaczmarek B had
reported that IOUS was helpful in 89% of patients with cystic lesions & 
inflammatory tumours of pancreas [80]. In our series, IOUS during surgery for 
pancreatitis was helpful in localizing un removed calculi, undrained cyst and 
localizing pseudoaneurysm. It facilitated the operation by reducing tissue 
traumatisation & blood loss. Machi et al had shown that previously planned 
procedures were changed because of OUS findings in 16.6% of 145 pancreatic 
operations for chronic pancreatitis [81]. 
Pain relief after surgery, including both the groups, is 82%. Following 
Frey’s procedure 70% to 80% of the patients with varying follow-up had good 
pain relief [41,82]. In the current series, 82% of the patients had complete pain 
relief and confirmed the observation made by others. The cause of poor pain 
outcome following surgery for chronic pancreatitis are multi factorial and 
include inadequate drainage of head, neuropathic changes and unrecognized 
cancer [83]. An incidence of 10% to 20% of persistent recurrent symptoms has 
been reported following Frey’s procedure [43]. Following LPJ, despite  early 
postoperative pain relief observed in 80% of patients, recurrent pain developed 
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within 3 to 5 years in up to 30% of patients [84]. The recurrence of pain was 
often attributed to persistent or recurrent disease in the head of the pancreas 
[85].  
Surgical procedures for chronic pancreatitis fail for several reasons: (1) 
the disease progresses in the head or another area of the gland; (2) an 
anastomotic stricture develops that no longer decompresses an obstructed duct; 
and (3) when pain is the major problem, irrespective of the surgical procedure 
performed, the perception of pain and the pain pathway persists. Confirmatory 
evidence shows that, if bouts of pancreatitis recur and enzymes are elevated, the 
pancreas is the source. If pain recurs and the presumption is recurrent 
pancreatitis, then duct and parenchymal studies are repeated. The decision to 
perform surgery involves similar thought processes as for an initial surgical 
procedure. The choices for surgical treatment depend on what was done 
previously. A failed drainage procedure usually is followed by a pancreatic 
resection; a failed resection, by total pancreatectomy; and a total 
pancreatectomy, by nerve ablation or nerve block. Success rates increase by 
only 15% to 20% for secondary surgical procedures. 
The preoperative incidence of diabetes in our series 39%. Frey reported 
11% of new onset of diabetes in his series of 50 patients followed over a period 
of 91 months [42] Prinz et al reorted of endocrine insufficiency rate of 50% in 
86 patients following LPJ followed up over a period of 24 years in 1981[5]. 
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Adams reported 23% incidence in1994 [4] & Bassi reported 11% in 1997 
following LPJ. Incidence of new onset diabetes after surgery is 4% in our series. 
This is less compared to literature evidence probably because of short duration 
of follow up. 
Preoperative incidence of   exocrine insufficiency in our series of patients 
is 25%. New onset of exocrine insuffiency following surgery was 16%. Frey 
reported 11% of new onset of steatorrhoea in his series of 50 patients followed 
over a period of 91 months.[42].  Izbicki et al reported incidence of 3% & 6% in 
his series in 1997 [86] & 1998[33] following LPJ-LHEP. Prinz et al reorted of 
exocrine insufficiency rate of 34% in 86 patients following LPJ followed up 
over a period of 24 years in 1981[4]. Adams reported 34% incidence in1994   
following LPJ. Our incidence is 15.7% following surgery this is comparable to 
literature evidence, but the follow up duration is very less.  
After surgery weight improved in 35% of our patients, it remained the 
same in 51% & decreased in 14%. Frey reported 64% weight gain, 33% lost 
weight & 1% remained unchanged in his series of 50 patients followed over a 
period of 91 months.[42]. Izbicki et al reported incidence of 78% & 81% 
increase in body weight his series in 1997[86] & 1998[33] following LPJ-
LHEP. 
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 Duration of surgery & blood loss during surgery are comparable to other 
centres. 
Strength & limitation:  
 No study has been exclusively done for utility of IOUS in surgery for 
chronic pancreatitis. Study population is acceptable to consider for an 
uncommon surgery. Both the groups are comparable in demography, etiology & 
pancreatic morphology. 
 Randomization was not a good method. 
 Pain reflects only one aspect of the sensitive and functional aspects of 
day-to-day living. Assessment of the quality of life by standardized 
psychometric measures, first introduced in the evaluation of outcome in cancer 
treatment, seems to be mandatory in the evaluation of therapeutic strategies in 
patients with chronic pancreatitis [87]. Assessment of pain by VAS alone is not 
sufficient to assess the outcome of surgery. 
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Conclusion 
 Intra operative ultra sonogram (IOUS) detected malignancy in one 
patient, there by altering the management. 
  IOUS was useful in 73% of our patients. IOUS enabled us to obtain more 
complete information & was useful in the complete evaluation of chronic 
pancreatitis to provide greater assurance that all structures that require drainage 
have been identified & managed.   
Pain relief though was slightly better in IUOS group, was not found to be 
statistically significant. 
  Duration of surgery was longer in IOUS group. Peroperative blood loss 
was lower in IOUS group, but was not statistically significant.  
Morbidity was similar in both groups.  
Short term outcome of weight gain, endocrine & endocrine insufficiency 
were not significantly altered by IOUS.  
 
 
52 
 
Referrence : 
1 The role of imaging ultrasound during pancreatic surgery, 104th Annual meeting of the 
American surgical association ,April 25-27,1984 
2 Grant CS, van Heerden J, Charboneau JW, et al.Insulinoma. The value of intraoperative 
ultrasonography.Arch Surg 1988;123:843 
3 Ebbehoj N, Svendsen LB, Madsen P: Pancreatic tissue pressure in chronic obstructive 
pancreatitis. Scand J Gastroenterol 19:1066-1068, 1984 
4 Adams DB, Ford MC, Anderson MC: Outcome after lateral pancreaticojejunostomy for 
chronic pancreatitis. Ann Surg 219:481-489, 1994 
5 Prinz RA, Greenlee HB: Pancreatic duct drainage in 100 patients with chronic 
pancreatitis. Ann Surg 194:313-320, 1981 
6 Bradley EL: Pancreatic duct pressure in chronic pancreatitis. Am J Surg 144:313-316, 
1982   
7 Ebbehoj N, Borly J, Madsen P, et al: Pancreatic tissue pressure and pain in chronic 
pancreatitis. Pancreas 4:556-558, 1990  
8 Frey CF: Why and when to drain the pancreatic ductal system. In Beger HG, Buechler 
MW, Ditschuneit H, et al (eds): Chronic Pancreatitis. Berlin, Springer-Verlag, 1990, pp 
415-425    
9 Bloechle C, Izbicki JR, Knoefel WT, et al: Quality of life in chronic pancreatitis: Results 
after duodenum-preserving resection of the head of the pancreas. Pancreas 11:77-85, 
1995 
10 Limmer JC, Knoefel WT, Bloechle C, et al: Correlation between intraductal and 
intraparenchymatous pancreatic pressure and pain in chronic pancreatitis (abstract). Int J 
Pancreatol 19:237, 1996   
53 
 
11 Karanjia ND, Widdison AL, Leung F, et al: Compartment syndrome in experimental 
chronic obstructive pancreatitis: Effect of decompressing the main pancreatic duct. Br J 
Surg 81:259-264, 1994   
12 Patel AG, Toyama MT, Alvarez C, et al: Pancreatic interstitial pH in human and feline 
chronic pancreatitis. Gastroenterology 109:1639-1645, 1995 
13 Keith RG, Keshavjee SH, Kerenyi NR: Neuropathology of chronic pancreatitis in 
humans. Can J Surg 28:207-211, 1985   
14 Lankisch PG, Happe-Loehr A, Otto J, et al: Natural course in chronic pancreatitis. 
Digestion 54:148-155, 1993 
15 Bockmann DE, Buechler M, Malfertheimer P, et al: Analysis of nerves in chronic 
pancreatitis. Gastroenterology 94:1459-1469, 1988   
16 Beger HG, Buechler M, Bittner R, et al: Duodenum-preserving resection of the head of 
the pancreas in severe chronic pancreatitis. Ann Surg 209:273-278, 1989   
17 Buechler M, Friess H, Mueller MW, et al: Randomized trial of duodenum preserving 
pancreatic head resection versus pylorus preserving Whipple in chronic pancreatitis. Am J 
Surg 169:65-70, 1995 
18 Partington PF, Rochelle RE: Modified Puestow procedure for retrograde drainage of the 
pancreatic duct. Ann Surg 152:1037-1042, 1960 
19  Harrison JL, Prinz RA. The surgical management of chronic pancreatitis: pancreatic duct 
drainage. Adv Surg 1999;32:1-21. 
20  Bradley EL. Long-term results of pancreatojejunostomy in patients with chronic 
pancreatitis. Am J Surg 1987;153: 207-213. 
21  Nealon WH, Thompson JC. Progressive loss of pancreatic function in chronic 
pancreatitis is delayed by main pancreatic duct decompression. A longitudinal 
prospective analysis of the modified Puestow procedure. Ann Surg 1993;217:458-468. 
54 
 
22  Wilson TG, Hollands MJ, Little JM. Pancreatojejunostomy for chronic pancreatitis. ANZ 
J Surg 1992;62:111-115. 
23 Nealon WH, Matin S.Analysis of surgical success in preventing recurrent acute 
exacerbations in chronic pancreatitis. Ann Surg 2001;233:793-800. 
24 Tantia O, Jindal MK, Khanna S, Sen B. Laparoscopic lateral pancreaticojejunostomy our 
experience of 17 cases. Surg Endosc 2004;18:1054-1057. 
25 Kurian MS, Gagner M. Laparoscopic side-to-side pancreaticojejunostomy (Partington-                         
Rochelle  for chronic pancreatitis. J Hepatobiliary Pancreat Surg 1999;6:382-386 
26 Rober HA. Chronic pancreatitis. In: Zinner MJ (ed). Maingot's abdominal operations, 
10th dn. Stamford: Appleton & Lange; 1997:1941-1960 
27 Prinz RA, Aranha GV, Greenlee HB.Redrainage of the pancreatic duct in chronic 
pancreatitis. Am J Surg 1986;151: 150-156. 
28 Traverso LW. The surgical management of chronic pancreatitis: the Whipple procedure. 
Adv Surg 1999;32:23-39 
29 Sakorafas GH, Tsiotou AG. Proximal pancreatectomy in the surgical management of 
chronic pancreatitis. J Clin Gastroenterol 2002;34:72-76. 
30 Beger HG, Krautzberger W, Bittner R, et al: Duodenum preserving resection of the head 
of the pancreas in patients with severe chronic pancreatitis. Surgery 97:467-473, 1985 
31 Frey CF, Smith GJ. Description and rationale of a new operation for chronic pancreatitis. 
Pancreas 1987;2:701-707. 
32 Traverso LW, Kozarek RA. Pancreatoduodenectomy for chronic pancreatitis: anatomic 
selection criteria and subsequent long-term outcome analysis. Ann Surg 1997; 226:429-
438. 
33 Izbicki JR, Bloechle C, Broering DC, et al: Extended drainage versus resection in surgery 
for chronic pancreatitis: Prospective randomized trial comparing the longitudinal 
55 
 
pancreaticojejunostomy combined with local pancreatic head excision with the pylorus 
preserving pancreatoduodenectomy. Ann Surg 228:771-779, 1998   
34 Grace PA, Pitt HA, Longmire WP. Pylorus-preserving pancreatoduodenectomy: an 
overview. Br J Surg 1990;77: 968-974. 
35 Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM. Gastrointestinal quality of 
life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a 
prospective, randomized study: pancreatoduodenectomy or pyloruspreserving 
pancreatoduodenectomy. Chirurg 1999;70: 1454-1459. 
36 White SA, Sutton CD, Weymss-Holden S, Berry DP,Polland C, Rees Y, Dennison AR. 
The feasibility of spleen-preserving pancreatectomy for end-stage chronic pancreatitis. 
Am J Surg 2000;179:294-297 
37 Schoenberg MH, Schlosser W, Ruck W, Beger HG. Distal pancreatectomy in chronic 
pancreatitis. Dig Surg 1999;16:130-136 
38 Warshaw AL, Banks PA, Fernadez-Del Castillo C. AGA technical review: treatment of 
pain in chronic pancreatitis. Gastroenterology 1998;115:765-776. 
39  Alexakis N, Ghaneh P, Connor S, Raraty M, Sutton R, Neoptolemos JP. Duodenum- and 
spleen-preserving total pancreatectomy for end-stage chronic pancreatitis. Br J Surg 
2003;90:1401-1408. 
40 Beger HG, Schlosser W, Friess HM, Buchler MW. Duodenum-preserving head resection 
in chronic pancreatitis changes the natural course of the disease: a single-center 26-year 
experience. Ann Surg 1999;230:512-523 
41 Frey CF. The surgical management of chronic pancreatitis: the Frey procedure. Adv Surg 
1999;32:41-85. 
56 
 
42 Frey CF, Amikura K: Local resection of the head of the pancreas combined with 
longitudinal pancreaticojejunostomy in the management of patients with chronic 
pancreatitis. Ann Surg 220:492-507, 1994 
43 Izbicki JR, Bloechle C, Knoefel WT, et al: Duodenum preserving resections of the head 
of the pancreas in chronic pancreatitis: A prospective randomized trial. Ann Surg 
221:350-358, 1995   
44 Warshaw AL: Conservation of pancreatic tissue by combined gastric, biliary, and 
pancreatic duct drainage for pain from chronic pancreatitis. Am J Surg 149:563-569, 1985  
45 Vijungco JD, Prinz RA. Management of biliary and duodenal complications of chronic 
pancreatitis. World J Surg 2003;27:1258-1270 
46 da Cunha JE, Bacchella T, Mott CB, Jukemura J, Abdo EE, Machado MC. Surgical 
treatment of biliary complications from calcifying chronic pancreatitis. Int Surg 
1984;69:149-54 
47 Bell RH Jr. Current surgical management of chronic pancreatitis. J Gastrointest Surg 
2005;9:144-154 
48 Uvaric M, Stimac D, Rubinic M, Kovac D, Zilli M, Petrosic N, et al. Duodenal 
obstruction from chronic pancreatitis. Minerva Chir 1997;52:885-889. 
49  Frey CF, Amikura K: Local resection of the head of the pancreas combined with 
longitudinal pancreaticojejunostomy in the management of patients with chronic 
pancreatitis. Ann Surg 220:492-507, 1994 
50 Usatoff V, Brancatisano R, Williamson RC. Operative treatment of pseudocysts in 
patients with chronic pancreatitis. Br J Surg 2000;87:1494-1499.            
51 Sakorafas GH, Sarr MG, Farley DR, Farnell MB. The significance of sinistral portal 
hypertension complicating chronic pancreatitis. Am J Surg 2000;179:129-133. 
57 
 
52 Heider TR, Azeem S, Galanko JA, Behrns KE. The natural history of pancreatitis-induced 
splenic vein thrombosis. Ann Surg 2004;239:876-882. 
53 Talamini G, Bassi C, Falconi M, Sartori N, Salvia R, Rigo L, et al. Alcohol and smoking 
as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci 1999;44:1303-
1311. 
54 Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, 
et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study 
Group. N Engl J Med 1993;328:1433-1437. 
55 Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK Jr, Perrault J, et al. 
Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary 
Pancreatitis Study Group. J Natl Cancer Inst 1997;89: 442-446. 
56 Gold EB, Gordis L, Diener MD, Seltser R, Boitnott JK, Bynum TE, et al. Diet and other 
risk factors for cancer of the pancreas. Cancer 1985; 55:460-7.    
57  Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage 
consumption and past medical history. J Natl Cancer Inst 1986; 76:49-60.   
58  Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and use of 
tobacco, alcohol and coffee. Int J Cancer 1990; 45:816-20.    
59  Jain M, Howe GR, St Louis P, Miller AB. Coffee and alcohol as determinants of risk of 
pancreatic cancer: a case-control study from Toronto. Int J Cancer 1991; 47:384-9.  
60  Kalapothaki V, Tzonou A, Hsieh CC, Toupadaki N, Trichopoulos D. Tobacco, ethanol, 
coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic 
carcinoma. Cancer Causes Control 1993; 4:1433-7.    
61 Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, 
et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study 
Group. N Engl J Med 1993; 328:1433-47.   
58 
 
62 Gold EB. Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 
1995; 75:819-43.   
63 Augustine P, Ramesh H. Is tropical pancreatitis premalignant? Am J Gastroenterol 1992; 
87:1005-8 
64 Chari ST, Mohan V, Pitchumoni CS, Viswanathan M, Madanagopalan N, Lowenfels AB. 
Risk of pancratic carcinoma in tropical calcifying pancreatitits: an epidemicologic study. 
Pancreas 1994; 9:62-6.     
65 Das K, Goenka MK, Wig JD, Nagi B, Bhasin D. Pancreatic carcinoma complicating 
tropical pancreatitis in north India. Indian J Gastroenterol 1996; 15:103.    
66  Mullens JE. Endoscopic retrograde cholangiopancreatography in the diagnosis of chronic 
pancreatitis. Surgery 1978;84:308-312. 
67  Lomanto D, Pavone P, Laghi A, Panebianco V, Mazzocchi P, Fiocca F, et al. Magnetic-
resonancecholangiopancreatography in the diagnosis of biliopancreatic diseases. Am J 
Surg 1997;174:33-38. 
68 Smith CD, Behrns KE, van Heerden JA, Sarr MG. Radical pancreatoduodenectomy for 
misdiagnosed pancreatic mass. Br J Surg 1994;81:585-589. 
69 Witz M, Shkolnik Z, Dinbar A. Intraoperative pancreatic biopsy--a diagnostic dilemma. J 
Surg Oncol 1989;42:117- 119. 
70 Printz H, Klotter HJ, Nies C, Hasse C, Neurath M, Sitter H, et al. Intraoperative 
ultrasonography in surgery for chronic pancreatitis. Int J Pancreatol 1992;12:233-237. 
71 Branum GD, Pappas TN, Meyers WC. The use of pancreatic ductoscopy in the operative 
management of benign and malignant pancreatic disorders. Surg Endosc 1995;9:53-55. 
72 Bloechle C, Izbicki JR, Knoefel WT, et al: Quality of life in chronic pancreatitis: Results 
after duodenum-preserving resection of the head of the pancreas. Pancreas 11:77-85, 
1995] 
59 
 
73 Ramesh H, Jacob G, Lekha V, et al. Ductal drainage with head coring in chronic 
pancreatitis with small-duct disease. J Hepatobiliary Pancreat Surg 2003;10;366 –72. 
74 Rault A, Sacunha A pancreatico jejuna anastomosis is preferable to 
pancreaticogastrostomy after pancreaticoduodenectomy for long term out comes of 
pancreatic exocrine function . J Am Coll Surg 2005;201:239-244 
75 Jakob R Izbicki et al surgical treatment of chronic pancreatitis and quality of life after 
operation . Surgical clinics of North America- vol 79.issue 4(Aug 1999) 
76 Tim Strate, Zohre Taherpour, Christian Bloechle, Izbicki et al. Long-term Follow-up of a 
Randomized Trial Comparing the Beger and Frey Procedures for Patients Suffering From 
Chronic Pancreatitis. Ann Surg 2005;241: 591–598  
77 Chaudary A, Negi SS, Massod S.Complications after Frey’s procedure for chronic 
pancreatitis.Am J Surg2004;188:277-281  
78 Makoweic F, Riediger H, Euringer W. Management of delayed visceral arterial bleeding 
after pancreatic head resection. J Gastrointest Surg 2005;9:1293-1299 
79 The role of imaging ultrasound during pancreatic surgery, 104th Annual meeting of the 
American surgical association ,April 25-27,1984 
80 value of operative ultrasonography during surgery for pancreatitis related changes of the 
pancreas[ Kaczmerk et al  PolishAnn Acad Med Stetin. 2000 
81 OPERATIVE Ultrasonography During Hepatobiliary and Pancreatic Surgery  Machi J; 
Sigel B; World J Surg, 17:640-646, 1993 
82 Pessaux P, Kianmanesh R, Regimbeau JM.Frey procedure in the treatment of chronic 
pancreatitis: short-term results.Pancreas 2006;33(4):354-358 
60 
 
83 Markowitz JS, Rattner DW, Warshaw AL. Failure of symptomatic relief after 
pancreaticojejunal decompression for chronic pancreatitis. Strategies for salvage.Arch 
surg 1994;129(4):374-379. 
84 Bradley EL. Long term results of pancreaticojejunostomy in patients    with chronic 
pancreatitis. Am J Surg 1987;153:207–13. 
85  Beger HG, Buchler M, Ditschnuneit H. Malfertheiner. Berlin, Germany:Springer-Verlag; 
1990:418. 
86 Izbicki JR, Bloechle C, Knoefel WT, et al: Drainage versus resektion in der chirurgischen 
therapie der chronischen kopfpankreatitis: Eine randomisierte studie. Chirurg 68:369-377, 
1997 
87 surgical treatment of chronic pancreatitis and quality of life after operation Surgical 
Clinics of North America - Volume 79, Issue 4 (August 1999)  - 1999 
88 Ammann RW, Akovblantz A, Largiader F,et al. Course and outcome of chronic 
pancreatitis. Gastroenterology. 1984; 86:820.  
89 Sharma AK, Pande GK, Sahni P, Nundy S: Surgery for nonalcoholic chronic pancreatitis. 
World J Surg 1998; 22:236-240.  
90 Agarwal G, Sikora SS, Choudhuria G, Bhatia E. Prospective study of pancreatic β-cell 
and exocrine function following duct decompression in tropical calcific pancreatitis. 
World J Surg 2002;26:171-175.  
91 Ramesh H, Augustine P. surgery in tropical pancreatitis: Analysis of risk factors. Br J 
Surg 1992;79:544.  
 
 
 
 
 
 
61 
 
Abbreviations :- 
1. AP  : Alcoholic Pancreatitis  
2. CECT :           Contrast Enhanced Computed Tomography 
3. CP  : chronic pancreatitis 
4. DP  :  Distal Pancreatectomy 
5. DPPHR : Duodenum-preserving pancreatic  head resection 
6. EUS  : Endo ultra sonogram 
7. FHA  : Fine Needle Aspiration 
8. IOUS  :         Intra operative ultrasonogram  
9. LPJ  : Longitudinal Pancreatico Jejunostomy 
10. LRLPJ          :       Local resection of the head with  lateral                                                       
   pancreaticojejunostomy  
11. MPD  : Main Pancreatic duct 
12. MRCP :           Magnetic ResonanceCholangioPancreatography 
13. PD                :          Pancreaticoduodenectomy 
14. PPPD           :          Pylorus preserving pancreaticoduodenectomy 
15. PPPD : Pylorus Preserving Pancreatico Duodenectomy 
16. TP  : Total Pancreatectomy 
17. TP  : Tropical Pancreatitis 
18. USG  : Ultrasonogram 
19. VAS  : Visual Analog Scale 
                   
 
Master chart code  
Diagnosis  :  1- TP  2- AP;                  Surgery : 1- Frey’s 2- LPJ  
VAS – pain score;                               DM- 1 – diabetic 2 – non diabetic 
Steatorrhoea  : 1- yes  2- no;               Weight loss : 1 – yes 2 – no  
Indication for surg :  1- pain 2 – bleed 
Mass head:  1- yes 2 – no 
IOUS : 1 – useful 2 – not useful 
Ious use  
1- Identified MPD 
2- Located calculi 
3- Identified undrained cyst 
4- Detected calculi & cyst  
5- Located pseudoaneursym  
6- Detected mass 
Morbidity :1-yes 2- no;                      Pain relief: 1 – yes 2- no 
DM  post op 
0- Non Dm no change  
1- New onset DM 
2- Pre op DM – same  
3- Pre op DM – non DM 
Wt post op  
 1 – Improved  
 2- Same 
3– Decreased  
Steatorrhoea post op 
 0 – no steat no change 
1- New onset 
2- Pre op steat – same 
3- Pre op steat – non steat. 
study 
no
age sex diag surgery
pain 
dur yrs
vas dm steat  wt loss
mass 
head
mpd 
mm
1 35 f 1 2 1 8 1 2 2 2 10
2 20 m 1 2 15 10 2 2 2 2 12
3 26 f 1 2 1 10 2 2 1 2 8
4 13 f 1 1 8 10 2 2 2 1 9
5 57 m 1 1 10 8 2 1 1 1 20
6 41 m 2 1 4 10 2 2 2 1 7
7 41 m 2 1 10 10 1 1 1 1 7
8 33 m 1 2 2 9 2 2 1 2 8
9 27 m 1 1 6 10 2 2 2 1 11
10 35 m 2 2 1 10 2 2 1 2 8
11 52 m 2 1 2 9 2 2 1 1 15
12 29 m 2 1 10 10 2 2 2 1 7
13 38 m 1 1 4 10 1 2 2 1 9
14 39 m 1 1 8 9 1 1 1 1 12
15 42 f 1 1 5 9 1 2 2 1 7
16 20 m 1 1 1 9 2 1 1 1 8
17 44 m 2 1 1 9 2 1 2 1 9
18 37 f 1 1 1 10 1 2 2 1 7
19 30 f 1 1 2 9 2 2 2 1 10
20 35 m 2 1 1 9 1 1 2 1 8
21 49 m 2 1 5 9 2 1 2 1 11
22 22 f 1 1 3 9 1 2 1 1 7
23 45 m 2 1 10 9 1 2 2 1 9
24 29 f 1 2 1 9 2 2 2 2 8
25 26 m 1 2 1 10 1 2 2 2 7
26 24 m 1 1 1 8 1 2 2 1 8
NON‐IOUS GROUP
study 
no
dur 
surg 
min
bl loss 
ml
p op 
stay days
morbidity
fol dur 
months
post op 
pain 
VAS
pain 
relief 
dm 
post op 
wt 
post op
steat 
post op
1 210 180 11 2 27 6 2 2 3 0
2 170 300 11 2 24 0 1 1 1 0
3 180 200 11 2 23 2 1 0 1 1
4 180 200 8 2 22 0 1 0 1 0
5 240 350 9 2 22 0 1 0 2 2
6 205 250 12 2 23 1 1 0 1 0
7 200 280 9 2 20 2 1 2 3 3
8 170 180 13 2 20 3 1 0 2 0
9 210 310 11 2 20 1 1 0 1 0
10 200 210 10 2 20 4 1 0 2 0
11 190 310 11 2 19 5 2 0 2 0
12 215 320 9 2 18 0 1 0 1 0
13 240 250 11 2 17 0 1 3 3 1
14 240 600 17 1 10 9 2 2 3 2
15 230 210 7 2 16 5 2 2 2 0
16 195 300 19 1 11 2 1 0 2 2
17 230 550 17 1 12 0 1 0 3 2
18 220 310 13 2 16 0 1 2 2 1
19 195 250 13 2 9 1 1 0 2 0
20 190 350 13 2 15 2 1 2 2 2
21 240 300 14 2 14 2 1 0 1 2
22 190 200 25 1 3 0 1 2 1 1
23 180 275 32 1 13 0 1 2 1 0
24 195 225 9 2 1 9 2 0 1 0
25 160 300 13 1 7 4 1 2 2 1
26 180 200 8 2 15 0 1 3 1 0
NON‐IOUS GROUP
